EGR ecograf limited

1.75%

28.0¢

Ann: Study Confirms Attractive Mechanical Shaping Opportunity, page-22

First 22 Last

Share
Profile

Follow
lectro

1,028 Posts.

397

19/09/23

15:39

Post #: 69918822
Share

Originally posted by Rothal2022: ↑

Yet another new study that sounds so promising, only to hear nothing about it a few months later. By the way, what happened to the joint study with Vermeer? Apart from the announcement, we've never heard anything about the results. Did Vermeer's machines ever actually arrive in Tanzania? But regardless, even the study must have cost money and probably won't be of any use since the strategy is likely to change again soon, leading to new studies. EGR should change its business model and focus on creating and profitably selling useless studies. That's something Andrew and his team are good at. They've been demonstrating it for 8 years and are world champions in producing useless studies and burning money with no added value for the company and shareholders. I'm curious how long the major shareholders will tolerate this behavior and the self-enrichment of the management.

Vote NO to this poor management in the next AGR!

Expand

They haven’t completed their university thesis yet. This could go on for years. Their object is to give the appearance of being VERY busy when in fact they are just doodling about completing assessment tasks to keep the gravy train running.

EGR Price at posting: 12.0¢ Sentiment: None Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 22 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 28.0¢		Change -0.005(1.75%)		Mkt cap ! $127.1M

Open	High	Low	Value	Volume
28.5¢	28.5¢	27.0¢	$73.01K	264.8K

Buyers (Bids)

No.	Vol.	Price($)
1	7272	27.5¢

Sellers (Offers)

Price($)	Vol.	No.
28.5¢	14597	1

View Market Depth

No.	Vol.	Price($)
1	7272	0.275
1	3700	0.270
3	93700	0.265
2	5423	0.260
2	11176	0.255

Price($)	Vol.	No.
0.285	14597	1
0.290	76322	3
0.295	147922	4
0.300	64300	5
0.305	3000	1

Last trade - 15.16pm 27/06/2025 (20 minute delay)

EGR (ASX) Chart

Ann: Study Confirms Attractive Mechanical Shaping Opportunity, page-22

Monash IVF shares cater 25% – Disaster or deep-value play?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Study Confirms Attractive Mechanical Shaping Opportunity, page-22

Top Stories

Monash IVF shares cater 25% – Disaster or deep-value play?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News